Meral Uyar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Meral Uyar has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Nazan Bayram
University of Gaziantep
9 shared publications Osman Elbek
Department of Pulmonary Medicine, Adnan Menderes University
7 shared publicationsAyten Filiz
Department of Respiratory Medicine, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey
5 shared publicationsKemal Bakir
Department of Pathology, Gaziantep University, Gaziantep, Turkey
4 shared publicationsNevhiz Gündoğdu
Department of Pulmonary Diseases, Gaziantep University, Gaziantep, 27035, Turkey
3 shared publicationsBerna Taskin-Dogan
Department of Pulmonary Medicine, Gaziantep, Turkey
2 shared publications
Latest Publications
- Open Access
- 27 May 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (3) , 278-283
The relationship between the need for prolonged oxygen therapy after discharge in COVID-19 patients and mortality
Aims: The COVID-19 pandemic has severely burdened healthcare systems worldwide due to the rapid rise in cases, often resulting in respiratory distress requiring oxygen therapy. However, research on the availability and long-term usage of oxygen concentrators upon discharge is limited. This study aimed to identify factors associated with the need for oxygen concentrators in discharged COVID-19 patients, as well as device acquisition and mortality rates. Methods: This study, conducted at a single center, comprised retrospective and prospective phases. Data were gathered from hospitalized COVID-19 patients, with follow-up conducted one year later for those prescribed oxygen concentrators at discharge. Sociodemographic and clinical variables were recorded, and statistical analyses were conducted to determine factors associated with oxygen concentrator need and duration of use. Results: Among 229 patients, 15.7% required oxygen concentrators at discharge. Factors associated with this need included older age, asthma, bilateral lung lesions, and the severity of lesions detected on thoracic computed tomography scans. Patients with corticosteroid use and hypertension required oxygen concentrators for over three months. Economic limitations impeded the acquisition of devices for 22.2% of patients who were prescribed them. Two to three months post-discharge, 72.2% of patients still used oxygen concentrators. Mortality analysis showed a 16.6% fatality rate among oxygen concentrator prescribed patients within one year, with shorter survival observed in those unable to obtain the device. Conclusion: This study highlights the significance of assessing factors impacting oxygen concentrator requirement in COVID-19 patients and their long-term prognosis. These findings should inform healthcare providers and policymakers in pandemic preparedness efforts, emphasizing tailored treatment approaches based on individual patient characteristics. Ensuring device accessibility and regular patient follow-up are crucial for optimizing healthcare delivery during similar crises.
- 27 May 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (3) , 278-283
Open AccessThe relationship between the need for prolonged oxygen therapy after discharge in COVID-19 patients and mortality
Aims: The COVID-19 pandemic has severely burdened healthcare systems worldwide due to the rapid rise in cases, often resulting in respiratory distress requiring oxygen therapy. However, research on the availability and long-term usage of oxygen concentrators upon discharge is limited. This study aimed to identify factors associated with the need for oxygen concentrators in discharged COVID-19 patients, as well as device acquisition and mortality rates. Methods: This study, conducted at a single center, comprised retrospective and prospective phases. Data were gathered from hospitalized COVID-19 patients, with follow-up conducted one year later for those prescribed oxygen concentrators at discharge. Sociodemographic and clinical variables were recorded, and statistical analyses were conducted to determine factors associated with oxygen concentrator need and duration of use. Results: Among 229 patients, 15.7% required oxygen concentrators at discharge. Factors associated with this need included older age, asthma, bilateral lung lesions, and the severity of lesions detected on thoracic computed tomography scans. Patients with corticosteroid use and hypertension required oxygen concentrators for over three months. Economic limitations impeded the acquisition of devices for 22.2% of patients who were prescribed them. Two to three months post-discharge, 72.2% of patients still used oxygen concentrators. Mortality analysis showed a 16.6% fatality rate among oxygen concentrator prescribed patients within one year, with shorter survival observed in those unable to obtain the device. Conclusion: This study highlights the significance of assessing factors impacting oxygen concentrator requirement in COVID-19 patients and their long-term prognosis. These findings should inform healthcare providers and policymakers in pandemic preparedness efforts, emphasizing tailored treatment approaches based on individual patient characteristics. Ensuring device accessibility and regular patient follow-up are crucial for optimizing healthcare delivery during similar crises.
- 28 March 2024
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 19 (1) , 1-7
Impact of Adaptive Servo-Ventilation in Heart Failure Patients
Background: Sleep related breathing disorders (SRBD) as obstructive apnea, central apnea and Cheyne-Stokes respiration (CSR) can be seen in patients with chronic heart failure. SRBD can influence prognosis of heart failure. Objective: To reveal sleep related breathing disorders in patients with heart failure and to display the effects of adaptive servo-ventilation (ASV) as a new therapy modality. Materials and Methods: In this prospective study, 32 patients with heart failure were included. One night polysomnography (PSG) was done. Results: According to the results of PSG, SRBD ratio was 96,7%. Continuous positive airway pressure (CPAP) and ASV titrations were offered to all patients with apnea-hypopnea index (AHI) > 5. Demographics and clinical properties, symptoms, PSG findings, presence of Cheyne-Stokes respiration (CSR), echocardiography results were recorded. Before and after ASV titration, pulmonary function tests, walking tests were performed, concentrations of transferrin and pro-BNP were determined. In the groups according to the AHI, severe OSAS in 18 of 30 patients, 4 moderate OSAS, 5 mild OSAS and 2 central sleep apnea (CSA). PSG and CPAP, ASV titrations done in 7 male and 1 female patients that obstructive apnea, central apnea, AHI, arousal and SpO2 min values had significant improvements (p=0,001 p=0,016 p=0,001 p=0,015 p=0,008 respectively). We determined all CSRs were eliminated with ASV. After ASV titration pro-BNP, walking distance and FVC values changed significantly (p=0,036 p=0,018 p=0,018 respectively). Conclusion: In the result, we determined cheyne-stokes respiration and central apneas persisted with CPAP but eliminated with one-night ASV application. ASV also decreased pro-BNP and increased FVC and walking distance values significantly.
- 28 March 2024
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 19 (1) , 1-7
Impact of Adaptive Servo-Ventilation in Heart Failure Patients
Background: Sleep related breathing disorders (SRBD) as obstructive apnea, central apnea and Cheyne-Stokes respiration (CSR) can be seen in patients with chronic heart failure. SRBD can influence prognosis of heart failure. Objective: To reveal sleep related breathing disorders in patients with heart failure and to display the effects of adaptive servo-ventilation (ASV) as a new therapy modality. Materials and Methods: In this prospective study, 32 patients with heart failure were included. One night polysomnography (PSG) was done. Results: According to the results of PSG, SRBD ratio was 96,7%. Continuous positive airway pressure (CPAP) and ASV titrations were offered to all patients with apnea-hypopnea index (AHI) > 5. Demographics and clinical properties, symptoms, PSG findings, presence of Cheyne-Stokes respiration (CSR), echocardiography results were recorded. Before and after ASV titration, pulmonary function tests, walking tests were performed, concentrations of transferrin and pro-BNP were determined. In the groups according to the AHI, severe OSAS in 18 of 30 patients, 4 moderate OSAS, 5 mild OSAS and 2 central sleep apnea (CSA). PSG and CPAP, ASV titrations done in 7 male and 1 female patients that obstructive apnea, central apnea, AHI, arousal and SpO2 min values had significant improvements (p=0,001 p=0,016 p=0,001 p=0,015 p=0,008 respectively). We determined all CSRs were eliminated with ASV. After ASV titration pro-BNP, walking distance and FVC values changed significantly (p=0,036 p=0,018 p=0,018 respectively). Conclusion: In the result, we determined cheyne-stokes respiration and central apneas persisted with CPAP but eliminated with one-night ASV application. ASV also decreased pro-BNP and increased FVC and walking distance values significantly.
- Open Access
- 7 November 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 698-705
Factors Affecting Treatment Compliance of Patients With COPD During the COVID-19 Pandemic
Objective: This study aimed to investigate the effects of difficulties experienced in the follow-up and treatment during the Coronavirus 2019 pandemic (COVID-19p), which included COVID-19 phobia and depression, on treatment compliance in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: This study included 123 patients with COPD. The COVID-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), and Medication Adherence Report Scale (MARS) were used to assess the patients. Results: The mean age of patients with COPD was 64.56 ± 9.31 years. It was determined that our patients did not maintain regular outpatient follow-up mostly because of the fear of COVID-19 transmission (78.8%). Overall, 24% of our patients showed treatment noncompliance. A statistically significant relationship was found between COPD stages B and D and treatment compliance (p=0.01). Patients with frequent emergency department admissions (p = 0.01) and those with high BDI (p = 0.01) and C19P-S (p = 0.02) scores during the pandemic were found to have reduced treatment compliance. Conclusion: Patients with COPD with COVID-19 phobia, and depression had reduced treatment compliance. İt is necessary to be aware of these conditions and to plan appropriate interventions.
- 7 November 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 698-705
Open AccessFactors Affecting Treatment Compliance of Patients With COPD During the COVID-19 Pandemic
Objective: This study aimed to investigate the effects of difficulties experienced in the follow-up and treatment during the Coronavirus 2019 pandemic (COVID-19p), which included COVID-19 phobia and depression, on treatment compliance in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: This study included 123 patients with COPD. The COVID-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), and Medication Adherence Report Scale (MARS) were used to assess the patients. Results: The mean age of patients with COPD was 64.56 ± 9.31 years. It was determined that our patients did not maintain regular outpatient follow-up mostly because of the fear of COVID-19 transmission (78.8%). Overall, 24% of our patients showed treatment noncompliance. A statistically significant relationship was found between COPD stages B and D and treatment compliance (p=0.01). Patients with frequent emergency department admissions (p = 0.01) and those with high BDI (p = 0.01) and C19P-S (p = 0.02) scores during the pandemic were found to have reduced treatment compliance. Conclusion: Patients with COPD with COVID-19 phobia, and depression had reduced treatment compliance. İt is necessary to be aware of these conditions and to plan appropriate interventions.
- 1 January 2023
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 116 (1) , 26-32
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome
Objectives: Pulmonary hypertension (PH) is common in obstructive sleep apnea syndrome (OSAS). This study aimed to evaluate the effect of PH on kidney functions in patients with OSAS. Methods: The data of patients who were diagnosed as having OSAS after referral to the sleep center in the Gaziantep University Medical Faculty between January 2005 and June 2017 were evaluated. The estimated...
- 1 January 2023
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 116 (1) , 26-32
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome
Objectives: Pulmonary hypertension (PH) is common in obstructive sleep apnea syndrome (OSAS). This study aimed to evaluate the effect of PH on kidney functions in patients with OSAS. Methods: The data of patients who were diagnosed as having OSAS after referral to the sleep center in the Gaziantep University Medical Faculty between January 2005 and June 2017 were evaluated. The estimated...
- 16 November 2017
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 13 (4) , 392-396
Diagnostic Usage of Low Dose CT in Solitary Pulmonary Nodule Follow Up in Daily Practice
Purpose: Numbers of computed tomography (CT) examinations are increasing, so does the number of patients exposed to ionizing radiation. Our aim was to reveal the current usage of low dose CT protocols in pulmonary nodule follow up in Gaziantep, Turkey, and what is more important to create awareness to the issue. Materials and Methods: A survey was conducted with specialists of chest diseases, thoracic surgeons and radiologists, regarding pulmonary nodule follow-up. At the end of the interview, brief information was given to the participants about the benefits of low dose CT. Results: Among 81 participants, 16 of the 39 radiologists (41.02%) stated that their CT scanners had a previously established low dose chest CT protocols by vendors, while 14 (35.89%) responded that they did not have any and 9 (23.07%) stated they did not know if they had. Twenty nine (74.35%) of the radiologists answered that they have not used the low dose protocols in nodule follow up before. Ninety five percent of clinicians were following a nodule 2 years before they excluded patients from follow up. Only 10 clinicians (23.8%) stated that they have requested low dose chest CT before, while remaining 32 (76.2%) answered they did not ever. Requested mean CT examination numbers during a follow up (except initial CT) were 5.87±2.01, and 6.42±2.15 for pulmonologists and thoracic surgeons, respectively (p=0.437). Conclusion: Follow up strategies of clinicians are consisted with recent literature knowledge, but low dose CT protocols in nodule follow up have not gained enough recognition in our city, yet. Physicians must be enlightened, and steps must be taken to generalize the use of low dose CT, especially in public hospitals, where vast majority of CT examinations are performed.
- 16 November 2017
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 13 (4) , 392-396
Diagnostic Usage of Low Dose CT in Solitary Pulmonary Nodule Follow Up in Daily Practice
Purpose: Numbers of computed tomography (CT) examinations are increasing, so does the number of patients exposed to ionizing radiation. Our aim was to reveal the current usage of low dose CT protocols in pulmonary nodule follow up in Gaziantep, Turkey, and what is more important to create awareness to the issue. Materials and Methods: A survey was conducted with specialists of chest diseases, thoracic surgeons and radiologists, regarding pulmonary nodule follow-up. At the end of the interview, brief information was given to the participants about the benefits of low dose CT. Results: Among 81 participants, 16 of the 39 radiologists (41.02%) stated that their CT scanners had a previously established low dose chest CT protocols by vendors, while 14 (35.89%) responded that they did not have any and 9 (23.07%) stated they did not know if they had. Twenty nine (74.35%) of the radiologists answered that they have not used the low dose protocols in nodule follow up before. Ninety five percent of clinicians were following a nodule 2 years before they excluded patients from follow up. Only 10 clinicians (23.8%) stated that they have requested low dose chest CT before, while remaining 32 (76.2%) answered they did not ever. Requested mean CT examination numbers during a follow up (except initial CT) were 5.87±2.01, and 6.42±2.15 for pulmonologists and thoracic surgeons, respectively (p=0.437). Conclusion: Follow up strategies of clinicians are consisted with recent literature knowledge, but low dose CT protocols in nodule follow up have not gained enough recognition in our city, yet. Physicians must be enlightened, and steps must be taken to generalize the use of low dose CT, especially in public hospitals, where vast majority of CT examinations are performed.
- 3 February 2017
- Published by Springer Nature in Sleep and Breathing
- Vol. 21 (4) , 1049
Renal functions in obstructive sleep apnea patients
- 3 February 2017
- Published by Springer Nature in Sleep and Breathing
- Vol. 21 (4) , 1049
Renal functions in obstructive sleep apnea patients
- Open Access
- 9 January 2017
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 26 (2) , 179-181
Tracheobronchomalacia as a Rare Cause of Chronic Dyspnea in Adults
Objective: To emphasize the importance of a careful clinical evaluation to prevent unnecessary interventions and treatments. Clinical Presentation and Intervention: A 76-year-old female patient had been diagnosed with asthma during previous admissions to different hospitals. She had also undergone fiberoptic bronchoscopy (FOB) on 2 occasions for evaluation of right middle lobe atelectasis observed on computed tomography. A repeated FOB revealed tracheobronchomalacia and nodular bronchial amyloidosis. A silicone Y stent was inserted, but the dyspnea increased. Excessive granulation tissue developed, and the patient died despite ventilatory support. Conclusion: The stenting technique used did not prevent the development of respiratory failure and death in this patient. Hence, a surgical procedure could be considered as an alternative to stenting in such cases.
- 9 January 2017
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 26 (2) , 179-181
Open AccessTracheobronchomalacia as a Rare Cause of Chronic Dyspnea in Adults
Objective: To emphasize the importance of a careful clinical evaluation to prevent unnecessary interventions and treatments. Clinical Presentation and Intervention: A 76-year-old female patient had been diagnosed with asthma during previous admissions to different hospitals. She had also undergone fiberoptic bronchoscopy (FOB) on 2 occasions for evaluation of right middle lobe atelectasis observed on computed tomography. A repeated FOB revealed tracheobronchomalacia and nodular bronchial amyloidosis. A silicone Y stent was inserted, but the dyspnea increased. Excessive granulation tissue developed, and the patient died despite ventilatory support. Conclusion: The stenting technique used did not prevent the development of respiratory failure and death in this patient. Hence, a surgical procedure could be considered as an alternative to stenting in such cases.
- 19 December 2016
- Published by Springer Nature in Sleep and Breathing
- Vol. 21 (2) , 475-478
Obstructive sleep apnea is the triggering factor for massive hemoptysis
Purpose The purpose of this study was to investigate the prevalence of obstructive sleep apnea (OSA) in patients with hemoptysis. Methods Files of patients who had undergone bronchial arterial embolization due to hemoptysis between 1 December 2009 and 2015 were evaluated and interviews of patients were conducted until 1 June 2016. Pittsburgh Sleep Quality Index (PSQI), STOP and STOP-BANG surveys were administered. OSA risk was determined with Berlin Questionnaire. Results Study group consisted of 53 patients and 58 control subjects. Mean age was 46.94 ± 14.36 and 41.97 ± 12.92 in patient and control group, respectively. Of these patients, seven had re-embolization procedure because of recurrence of hemoptysis. High OSA risk was more common among patients with hemoptysis (24.5%, n = 13) than the control group (8.6%, n = 5) (p = 0.023). Percentage of high risk OSA patients with massive hemoptysis, nonmassive hemoptysis, and control subjects was 29.7% (n = 11), 12.5% (n = 2), and 8.6% (n = 5), respectively (p = 0.022). There were more high OSA risk subjects among patients with idiopathic hemoptysis 44.4% (four out of nine), while 20.5% (nine out of 53) patients with a known etiology had high risk (p = 0.127). The number of patients with high OSA risk was also higher in patients who required a second embolization procedure (four out of seven, 57.1%), while 19.6% of patients without need for re-embolization had high risk (p = 0.031). Conclusions OSA is found to be a risk factor for hemoptysis and also may provoke massive hemoptysis. It seems reasonable to consider OSA as an underlying condition in idiopathic hemoptysis. OSA may contribute to embolization failure.
- 19 December 2016
- Published by Springer Nature in Sleep and Breathing
- Vol. 21 (2) , 475-478
Obstructive sleep apnea is the triggering factor for massive hemoptysis
Purpose The purpose of this study was to investigate the prevalence of obstructive sleep apnea (OSA) in patients with hemoptysis. Methods Files of patients who had undergone bronchial arterial embolization due to hemoptysis between 1 December 2009 and 2015 were evaluated and interviews of patients were conducted until 1 June 2016. Pittsburgh Sleep Quality Index (PSQI), STOP and STOP-BANG surveys were administered. OSA risk was determined with Berlin Questionnaire. Results Study group consisted of 53 patients and 58 control subjects. Mean age was 46.94 ± 14.36 and 41.97 ± 12.92 in patient and control group, respectively. Of these patients, seven had re-embolization procedure because of recurrence of hemoptysis. High OSA risk was more common among patients with hemoptysis (24.5%, n = 13) than the control group (8.6%, n = 5) (p = 0.023). Percentage of high risk OSA patients with massive hemoptysis, nonmassive hemoptysis, and control subjects was 29.7% (n = 11), 12.5% (n = 2), and 8.6% (n = 5), respectively (p = 0.022). There were more high OSA risk subjects among patients with idiopathic hemoptysis 44.4% (four out of nine), while 20.5% (nine out of 53) patients with a known etiology had high risk (p = 0.127). The number of patients with high OSA risk was also higher in patients who required a second embolization procedure (four out of seven, 57.1%), while 19.6% of patients without need for re-embolization had high risk (p = 0.031). Conclusions OSA is found to be a risk factor for hemoptysis and also may provoke massive hemoptysis. It seems reasonable to consider OSA as an underlying condition in idiopathic hemoptysis. OSA may contribute to embolization failure.
- 9 August 2016
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 39 (3) , 345-348
An unusual course of aortic arch through an accessory fissure of left upper lobe of the lung: extramediastinal aortic arch
In this case report, we present an unexpected, extramediastinal course of aortic arch through an accessory fissure of left upper lobe of the lung in a 19-year-old healthy man.
- 9 August 2016
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 39 (3) , 345-348
An unusual course of aortic arch through an accessory fissure of left upper lobe of the lung: extramediastinal aortic arch
In this case report, we present an unexpected, extramediastinal course of aortic arch through an accessory fissure of left upper lobe of the lung in a 19-year-old healthy man.
- 18 June 2015
- Published by Springer Nature in Sleep and Breathing
- Vol. 20 (1) , 191-195
Renal functions in obstructive sleep apnea patients
The aim of this study is to investigate possible factors influencing glomerular filtration rate (GFR) in obstructive sleep apnea (OSA). Data of OSA patients admitted to Gaziantep University sleep clinic from January 2005 to January 2010 were retrospectively evaluated. GFR is calculated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Patients younger than 18 years old were excluded. The mean age of OSA (n = 634) and control group (n = 62) were 51.13 ± 11.61 and 50.69 ± 13.88 years, respectively (p = 0.81). The mean estimated GFR (eGFR) was 90.73 ± 19.59 ml/min/1.73 m2 in OSA patients and 94.14 ± 18.81 ml/min/1.73 m2 in control subjects (p = 0.19). GFR was 84.25 ± 20.87 ml/min/1.73 m2 in patients with left ventricular hypertrophy (LVH) while it was 93.94 ± 18.44 ml/min/1.73 m2 in patients without LVH (p = 0.00). GFR of male subjects was 92.1 ± 19.23 in OSA and 95.84 ± 20.08 ml/min/1.73 m2 in controls (p = 0.33). GFR of female and male patients in the OSA were 87.45 ± 20.10 and 92.91 ± 18.02 ml/min/1.73 m2, respectively (p = 0.13). Serum creatinine was higher in OSA patients compared to controls (p = 0.01). GFR was 92.30 ± 19.27 in male and 88.33 ± 19.84 ml/min/1.73 m2 in female subjects (p = 0.01). GFR was 84.86 ± 19.95 in hypertensive patients while it was 95.11 ± 18.20 ml/min/1.73 m2 in normotensive subjects (p = 0.00). GFR was 89.30 ± 19.96 in patients with metabolic syndrome (MetS) and it was 93.46 ± 18.68 ml/min/1.73 m2 in patients without MetS (p = 0.00). GFR values were lower in sleep apneic patients with MetS as well as in patients with hypertension and LVH.
- 18 June 2015
- Published by Springer Nature in Sleep and Breathing
- Vol. 20 (1) , 191-195
Renal functions in obstructive sleep apnea patients
The aim of this study is to investigate possible factors influencing glomerular filtration rate (GFR) in obstructive sleep apnea (OSA). Data of OSA patients admitted to Gaziantep University sleep clinic from January 2005 to January 2010 were retrospectively evaluated. GFR is calculated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Patients younger than 18 years old were excluded. The mean age of OSA (n = 634) and control group (n = 62) were 51.13 ± 11.61 and 50.69 ± 13.88 years, respectively (p = 0.81). The mean estimated GFR (eGFR) was 90.73 ± 19.59 ml/min/1.73 m2 in OSA patients and 94.14 ± 18.81 ml/min/1.73 m2 in control subjects (p = 0.19). GFR was 84.25 ± 20.87 ml/min/1.73 m2 in patients with left ventricular hypertrophy (LVH) while it was 93.94 ± 18.44 ml/min/1.73 m2 in patients without LVH (p = 0.00). GFR of male subjects was 92.1 ± 19.23 in OSA and 95.84 ± 20.08 ml/min/1.73 m2 in controls (p = 0.33). GFR of female and male patients in the OSA were 87.45 ± 20.10 and 92.91 ± 18.02 ml/min/1.73 m2, respectively (p = 0.13). Serum creatinine was higher in OSA patients compared to controls (p = 0.01). GFR was 92.30 ± 19.27 in male and 88.33 ± 19.84 ml/min/1.73 m2 in female subjects (p = 0.01). GFR was 84.86 ± 19.95 in hypertensive patients while it was 95.11 ± 18.20 ml/min/1.73 m2 in normotensive subjects (p = 0.00). GFR was 89.30 ± 19.96 in patients with metabolic syndrome (MetS) and it was 93.46 ± 18.68 ml/min/1.73 m2 in patients without MetS (p = 0.00). GFR values were lower in sleep apneic patients with MetS as well as in patients with hypertension and LVH.